Arthritis & Rheumatism

Anifrolumab shows long-term promise in patients with lupus

Type I interferon (IFN) is a powerful immune activator that is present at high levels in the majority of patients with lupus, an autoimmune disease. In Arthritis & Rheumatology, researchers report positive results from the ...

Health

Sleep deprivation may increase risk for systemic lupus in women

Lack of sleep is associated with an increased risk for systemic lupus erythematosus (SLE), particularly among women with concomitant depression or bodily pain, according to a study published online Sept. 12 in Arthritis Care ...

Neuroscience

New study focuses on improving cognitive symptoms of lupus

A National Jewish Health led study recently published in Lupus finds that technology using video game-based cognitive therapy improves attention and executive functioning in patients with systemic lupus erythematosus (SLE).

page 7 from 27